ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) represents 15–20% of breast cancer cases and is associated with a lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expression [2].